Your browser doesn't support javascript.
loading
The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model.
Crathorne, Louise; Huxley, Nicola; Haasova, Marcela; Snowsill, Tristan; Jones-Hughes, Tracey; Hoyle, Martin; Briscoe, Simon; Coelho, Helen; Long, Linda; Medina-Lara, Antonieta; Mujica-Mota, Ruben; Napier, Mark; Hyde, Chris.
Afiliação
  • Crathorne L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
  • Huxley N; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
  • Haasova M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
  • Snowsill T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
  • Jones-Hughes T; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
  • Hoyle M; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
  • Briscoe S; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
  • Coelho H; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
  • Long L; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
  • Medina-Lara A; University of Exeter Medical School, Exeter, UK.
  • Mujica-Mota R; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
  • Napier M; Royal Devon and Exeter Hospital, Exeter, UK.
  • Hyde C; Peninsula Technology Assessment Group (PenTAG), University of Exeter Medical School, Exeter, UK.
Health Technol Assess ; 20(13): 1-588, v-vi, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26907163

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Análise Custo-Benefício / Hematínicos / Anemia / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Avaliação da Tecnologia Biomédica / Análise Custo-Benefício / Hematínicos / Anemia / Neoplasias Idioma: En Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido